HLB Fails to Receive US FDA Approval for Rivoceranib Liver Cancer Treatment
The logo of HLB HLB has failed to secure approval from the U.S. Food and Drug...
cancer
NHS approves ‘invaluable’ treatment for liver cancer which can help speed up recovery
Sign up for our free Health Check email to receive exclusive analysis on the week in healthGet our free Health...
Study identifies driver of liver cancer that could be target for treatment
Single-cell RNA sequencing identifies FABP5 upregulation during HCC progression. Credit: Nature Metabolism (2024). DOI: 10.1038/s42255-024-01019-6 Metabolic diseases like obesity can...
Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses | Fox Chase Cancer Center
In a study presented today at the American Urological Association Annual Meeting 2024, Robert Wang, MD, lead author and a...
Liver Cancer Drugs Market Size to Capture USD 9.94 Bn Leading at 14.2% of CAGR by 2032
The liver cancer drugs market size was worth USD 2.67 billion in 2023 is expected to grow to USD 9.94...
Identifying Good Candidates for Active Surveillance of Kidney Cancer
With more abdominal imaging catching kidney cancer earlier on when tumors are smaller, there has been an increasing trend in...
